RxDoctor Payments Data

Daniel Petereit, MD

Radiation Oncology · Rapid City, SDNPI 1568457257

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,489 of the $6,360 with a category attached, or 70.6%. 38 manufacturers reported payments, led by Boston Scientific at 41.0% of the total. Reporting peaked in 2021 at $2,686 and has fallen 50.2% since, to $1,338 in 2025.

$6,360in general payments, 2019–2025

Across 95 payments — averaging $66.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Theragenics Corporation$1K
  • Siemens Medical Solutions USA, Inc.$539
  • Elekta, Inc.$387
  • Arrow International, Inc.$144
  • AstraZeneca$135
  • plus $1K from 32 others

What the payments were for

  • Consulting fees$1,83829%
  • Food & beverage$4,48971%
  • Entertainment$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few radiation oncology providers in South Dakotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$239,750
Medicare patients
410
Services billed
2,567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl213$2,627
Tolterodine Tartrate ErTolterodine Tartrate11$1,197
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$765
Oxycodone Hcl13$446
Dexamethasone12$443
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine13$373
Lidocaine Hcl ViscousLidocaine Hcl13$338
Venlafaxine Hcl ErVenlafaxine Hcl22$180
Methylprednisolone19$142
Sertraline Hcl11$50
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim32$46
Ciprofloxacin Hcl20$39

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Rapid City

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →